Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00097 | 1 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00021 | 1 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 3.6e-06 | 1 |